Absorb GT1 Japan PMS

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 135 participants.

Also called NCT03409731

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 135 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03409731
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03409731. Allocation not applicable; no masking; primary purpose prevention. Start 2016-12-13 (actual); primary completion 2023-02-06 (actual). Results posted on 2019-01-03.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Absorb GT1 Japan PMS
Condition
Ischemic Heart Disease
Condition
Angina Pectoris
Condition
Coronary Artery Occlusion
Condition
Myocardial Ischemia
Intervention (Device)
ABSORB GT1 BVS
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct03409731
Content hash
f634dc07e1e2dbc2106e65da0a69cc8ac89a6035e2cdfefc9cb429388b295511